PepTrackevidence-graded reference
Honest reference

Explore

Search every compound — each graded A–E against real evidence, fully sourced, zero hype.

Evidence
Sort
18 compounds
Semaglutide
Metabolic · FDA-approved RCTs · FDA-approved
Aevidence
Tirzepatide
Metabolic · FDA-approved RCTs · FDA-approved
Aevidence
Retatrutide
Metabolic · human trials · Investigational
Bevidence
BPC-157
Healing & recovery · animal-only · Removed from Cat 2 · pending PCAC
Devidence
GHK-Cu
Cosmetic / skin · human trials · Removed from Cat 2 · pending PCAC
Bevidence
TB-500 (Thymosin beta-4 fragment)
Healing & recovery · animal-only · Removed from Cat 2 · pending PCAC
Devidence
CJC-1295 / Ipamorelin
GH secretagogue · human trials · Removed from Cat 2 · pending PCAC
Bevidence
PT-141 (Bremelanotide)
Sexual health · FDA-approved RCTs · Category 2 — restricted
Aevidence
Tesamorelin
GH secretagogue · FDA-approved RCTs · FDA-approved
Aevidence
Sermorelin
GH secretagogue · human trials · Research-use-only — gray market
Bevidence
Cagrilintide / CagriSema
Metabolic · human trials · Investigational
Bevidence
MOTS-c
Metabolic · animal-only · Removed from Cat 2 · pending PCAC
Devidence
Epitalon (Epithalon)
Longevity · mechanistic / anecdotal · Removed from Cat 2 · pending PCAC
Eevidence
Selank
Cognitive · human trials · Category 2 — restricted
Bevidence
Semax
Cognitive · human trials · Removed from Cat 2 · pending PCAC
Bevidence
NAD+ (and precursors NMN/NR)
Longevity · mechanistic / anecdotal · Research-use-only — gray market
Eevidence
Melanotan II
Cosmetic / skin · human trials · Banned / prohibited
Bevidence
KPV
Immune / gut · animal-only · Removed from Cat 2 · pending PCAC
Devidence
Peptide tracker · honest reference

Track your
stack.

Log your doses and cycles, check how compounds interact, and see every one graded against real evidence — A to E, fully sourced, zero hype.

18
compounds
reviewed
4
FDA-approved
anchors
12
gray-market /
reclassified
6
animal-only or
weaker evidence
Reviewed June 2026· re-verify regulatory & dosing claims before acting · not medical advice
01
Graded by real evidence
Every claim rated A–E — from human RCTs down to anecdote, never vendor hype dressed as fact.
02
Claims checked against the evidence
What the studies actually found — and what they didn’t — instead of the marketing version.
03
The regulatory truth
“Removed from Category 2” ≠ legal to compound ≠ FDA-approved. We say so plainly, with dates.
18 compounds
gradeABCDEstrongest → weakest
Regulatory status
Route
1
Semaglutide
Ozempic · Wegovy
Metabolic
AFDA-approved RCTs
FDA-approved
Subcutaneous · Oral
→
2
Tirzepatide
Mounjaro · Zepbound
Metabolic
AFDA-approved RCTs
FDA-approved
Subcutaneous
→
3
Retatrutide
LY-3437943 · triple-G
Metabolic
Bhuman trials
Investigational
Subcutaneous
→
4
BPC-157
Body Protection Compound-157 · stable gastric pentadecapeptide
Healing & recovery
Danimal-only
Removed from Cat 2 · pending PCAC
Subcutaneous · Intramuscular · Oral
→
5
GHK-Cu
Copper Tripeptide-1 · GHK copper
Cosmetic / skin
Bhuman trials
Removed from Cat 2 · pending PCAC
Topical · Subcutaneous · Microneedling
→
6
TB-500 (Thymosin beta-4 fragment)
Ac-LKKTETQ · Tbeta4 17-23
Healing & recovery
Danimal-only
Removed from Cat 2 · pending PCAC
Subcutaneous · Intramuscular
→
7
CJC-1295 / Ipamorelin
mod-GRF(1-29) · NNC 26-0161
GH secretagogue
Bhuman trials
Removed from Cat 2 · pending PCAC
Subcutaneous
→
8
PT-141 (Bremelanotide)
Vyleesi
Sexual health
AFDA-approved RCTs
Category 2 — restricted
Subcutaneous · Intranasal
→
9
Tesamorelin
Egrifta · Egrifta SV
GH secretagogue
AFDA-approved RCTs
FDA-approved
Subcutaneous
→
10
Sermorelin
GHRH(1-29) · GRF 1-29
GH secretagogue
Bhuman trials
Research-use-only — gray market
Subcutaneous
→
—
Cagrilintide / CagriSema
amylin analog · cagrilintide + semaglutide
Metabolic
Bhuman trials
Investigational
Subcutaneous
→
—
MOTS-c
mitochondrial-derived peptide
Metabolic
Danimal-only
Removed from Cat 2 · pending PCAC
Subcutaneous
→
—
Epitalon (Epithalon)
AEDG · pineal tetrapeptide
Longevity
Emechanistic / anecdotal
Removed from Cat 2 · pending PCAC
Subcutaneous · Intramuscular · Sublingual
→
—
Selank
TP-7 · tuftsin analog
Cognitive
Bhuman trials
Category 2 — restricted
Intranasal · Subcutaneous
→
—
Semax
ACTH(4-7)PGP · MEHFPGP
Cognitive
Bhuman trials
Removed from Cat 2 · pending PCAC
Intranasal · Subcutaneous
→
—
NAD+ (and precursors NMN/NR)
nicotinamide adenine dinucleotide · NMN
Longevity
Emechanistic / anecdotal
Research-use-only — gray market
Oral · Subcutaneous · IV
→
—
Melanotan II
MT-II · MT2
Cosmetic / skin
Bhuman trials
Banned / prohibited
Subcutaneous · Intranasal
→
—
KPV
Lys-Pro-Val · alpha-MSH C-terminal fragment
Immune / gut
Danimal-only
Removed from Cat 2 · pending PCAC
Subcutaneous · Oral · Topical
→
Not medical or legal advice. Educational / harm-reduction reference. This field moves monthly — re-verify regulatory and dosing claims against primary sources (FDA docket FDA-2025-N-6895, DailyMed, ClinicalTrials.gov) before acting.